Introduction In the development of terminology of the lower urinary tract, due to its increasing
complexity, the terminology for male lower urinary tract and pelvic floor symptoms and …

Current Treatment for Benign Prostatic Hyperplasia - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Purpose: We present final 5-year outcomes of the multicenter randomized sham-controlled
trial of a water vapor therapy (Rezūm™) for treatment of moderate to severe lower urinary …

Context Understanding men's values and preferences in the context of personal, physical,
emotional, relational, and social factors is important in optimising patient counselling …

Materials and methods: We provide a review on the evolution of HoLEP as a gold standard
compared to the historical reference procedures for BPH, and provide a review of emerging …

Purpose Assess long-term outcomes of prostatic artery embolization (PAE) for patients with
benign prostatic hyperplasia (BPH). Materials and Methods Single centre retrospective study …

Context Prostatic artery embolization (PAE) has been introduced into clinical practice for the
treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH …

Objectives To comprehensively evaluate the efficacy and safety of the hexanic extract of
Serenoa repens (HES r, Permixon®; Pierre Fabre Médicament, Castres, France), at a dose …

Background Human ejaculation can be defined as a complex and still largely unknown
function. Since decades, Benign Prostatic Hyperplasia (BPH) surgery-associated loss of …

Rezum is a minimally invasive transurethral water vapour therapy for benign prostatic
enlargement which uses thermal energy for treatment. The short-term results show it to have …